Webinar – PDX Platform for Clinical Advancement of Oncology Agents
Find out how the Champions TumorGraft platform is being used for conducting high-throughput translational medicine trials across a multitude of patient tumor models, including acute myelogenous leukemia (AML). Additionally, hear how co-clinical and matched PDX-directed trials are being implemented through several industry and academic partnerships.
- Introduction to the PDX algorithm
- Overview of Champions Oncology PDX tumor bank
- Overview of Champions Oncology co-clinical program
- AML modeling
- CD34+ HSC-derived humanized PDX models for immuno-therapy testing